The B Hub
Resource Library
Welcome to our Resource Library Blog page, where you can discover valuable content tailored to your specific interests and needs. Whether you're seeking information on the latest advancements in hemophilia B treatment or looking for personal stories from individuals with hemophilia B, this is the place to be. With our convenient filter options or by exploring the dedicated hubs, you can easily access articles that resonate with you on a deeper level. Take advantage of this resource and empower yourself with knowledge and insights that are relevant to your unique journey.
Controversy over ISTH Hemophilia Treatment Guidelines
A controversy over a set of clinical treatment guidelines has been raging for over a year now, but you probably haven’t heard about it.
Pfizer Advocacy Meeting
Updates from Pfizer’s Rare Disease Advocacy Collaborative held December 2024.
Hemophilia Landscape Emerging Therapies
Dr. Clark on treatments for hemophilia B patients.
Kim Phelan Speaks at Congressional Briefing on Gene Therapies
Kim Phelan Speaks on Panel at the Institute for Gene Therapies
Intradermal Injection Can Cause Inhibitor Development
Most B inhibitor patients probably did not acquire their inhibitors by ID contact, but it’s possible and needs more study.
Is Inhibitor Development Affected by the Product Used?
Hemophilia B suffers from having too few patients as subjects for research. Because of that, some of the knowledge about hemophilia B is extrapolated from studies of hemophilia A.
Hemophilia Carrier Screening
The average time to diagnosis for females was seven years later than for males.